PD-L1-

Frederik A Stuebs1, Antje Knöll2, Arndt Hartmann3

  • 1Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.

Gynecologic oncology
|January 11, 2025
PubMed
概括

在状细胞癌 (VSCC) 中PD-L1表达与预后较差相关. 这一发现表明PD-L1可能是治疗癌的免疫检查点抑制剂的目标.